Value of albumin-bilirubin grade in predicting liver function changes and prognosis of hepatocellular carcinoma patients undergoing transarterial chemoembolization: A Meta-analysis

QR Code

Value of albumin-bilirubin grade in predicting liver function changes and prognosis of hepatocellular carcinoma patients undergoing transarterial chemoembolization: A Meta-analysis

ObjectiveTo investigate the value of albumin-bilirubin (ALBI) grade in evaluating liver function changes and prognosis of hepatocellular carcinoma (HCC) patients undergoing transarterial chemoembolization (TACE). MethodsPubMed, the Cochrane Library, EMbase, Web of Science, OVID, CNKI, Wanfang Data,...

Description complète

Enregistré dans:

Détails bibliographiques
Auteur principal:	YU Weiming
Format:	article
Langue:	ZH
Publié:	Editorial Department of Journal of Clinical Hepatology 2021
Sujets:	Diseases of the digestive system. Gastroenterology RC799-869
Accès en ligne:	https://doaj.org/article/c3e1653b78434ed6bcb2c3873e8b30bb
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Transarterial chemoembolization using iodized oil for unresectable hepatocellular carcinoma: perspective from multistep hepatocarcinogenesis
par: Yoshimitsu K
Publié: (2014)

Transarterial chemoembolization with drug-eluting beads versus conventional transarterial chemoembolization in locally advanced hepatocellular carcinoma
par: Baur J, et autres
Publié: (2016)

Development of a Model to Predict Liver Decompensation prior to Transarterial Chemoembolization Refractoriness in Patients with Intermediate-Stage Hepatocellular Carcinoma
par: Joel Ferreira-Silva, et autres
Publié: (2021)

An excerpt of EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis-2021 update
par: ZHANG Yue
Publié: (2021)

Impact of cone-beam computed tomography with automated feeder detection software on the survival outcome of patients with hepatocellular carcinoma during treatment with conventional transarterial chemoembolization
par: Kittipitch Bannangkoon, et autres
Publié: (2021)

Hepatocellular Carcinoma Prevention by Aspirin: Are Platelets the Link?
par: Hans Dieter Nischalke, et autres
Publié: (2021)

Current and Emerging Tools for Hepatocellular Carcinoma Surveillance
par: Nia Adeniji, et autres
Publié: (2021)

Biomarkers for hepatocellular carcinoma: diagnostic and therapeutic utility
par: Ferrín G, et autres
Publié: (2015)

Clinical features and prognosis of primary myelofibrosis with hepatic vascular disease and/or portal hypertension
par: WANG Jing
Publié: (2021)

Epidemiology of drug-induced liver injury
par: LI Xiaoyun
Publié: (2021)

Association between liver fibrosis progression and endothelin-1/nitric oxide in patients with nonalcoholic fatty liver disease
par: LI Pinhua
Publié: (2021)

Percutaneous hepatic radiofrequency for hepatocellular carcinoma: results and outcome of 46 patients
par: Bertr, et autres
Publié: (2015)

Clinical manifestations and typing of drug-induced liver injury
par: YANG Wanna
Publié: (2021)

Drug-induced liver injury: Advances and confusions in treatment
par: CHEN Shuai
Publié: (2021)

Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis, and therapeutics
par: Dhanasekaran R, et autres
Publié: (2012)

Pathological features and pathological diagnosis of drug-induced liver injury
par: YANG Yongfeng
Publié: (2021)

Critical reappraisal of risk factors for occurrence of hepatocellular carcinoma in patients with hepatitis C virus
par: Bruno S, et autres
Publié: (2011)

Pathogenesis of drug-induced liver injury: Current understanding and future needs
par: YU Yuecheng
Publié: (2021)

Weekly cisplatin may reverse liver dysfunction and jaundice caused by diffuse liver metastases of solid tumors
par: M Gabrovska, et autres
Publié: (2009)

Clinical features of drug-induced liver failure and related diagnosis and treatment strategies
par: LAI Rongtao
Publié: (2021)

Prevalence rate of non-obese fatty liver disease and related influencing factors
par: DENG Jiang
Publié: (2021)

Autonomic dysfunction in chronic liver disease
par: Frith J, et autres
Publié: (2011)

The Ratio of Platelets to Lymphocytes Predicts the Prognosis of Metastatic Colorectal Cancer: A Review and Meta-Analysis
par: Jinming Wang, et autres
Publié: (2021)

An excerpt of Budd-Chiari syndrome: Consensus guidance of the Asian Pacific Association for the Study of the Liver (APASL)
par: WANG Xueying
Publié: (2021)

GLP-1 Receptor Agonist Effects on Lipid and Liver Profiles in Patients with Nonalcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis
par: Shahla Rezaei, et autres
Publié: (2021)

Construction of a new patient-derived xenograft model of human liver cancer in mice with normal immunity
par: TANG Huixin
Publié: (2021)

A preliminary study on percutaneous transhepatic drainage combined with sequential percutaneous nephroscopy in treatment of refractory liver abscess
par: DUAN Changhu
Publié: (2021)

Evolving concepts in the selection of immunosuppression regimen for liver transplant recipients
par: Locke JE, et autres
Publié: (2011)

Lifestyle interventions for the treatment of non-alcoholic fatty liver disease
par: Bradford V, et autres
Publié: (2013)

An excerpt of diagnosis, evaluation, and management of ascites and hepatorenal syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases
par: HU Jiaxuan
Publié: (2021)

Hepatocyte-specific TM6SF2 knockout aggravates hepatic steatosis in mice with nonalcoholic fatty liver disease
par: ZHANG Jie
Publié: (2021)

Therapeutic effect of Taohong Siwu decoction on a mouse model of carbon tetrachloride-induced liver fibrosis and its mechanism
par: LIU Xuling
Publié: (2021)

Surgical treatment of nonalcoholic fatty liver disease in severely obese patients
par: Vander Naalt SJ, et autres
Publié: (2014)

A serum metabolomics study on the intervention of nonalcoholic fatty liver disease by equicaloric low-carbohydrate high-protein diet combined with aerobic exercise
par: LI Meiying
Publié: (2021)

Tyrosine levels are associated with insulin resistance in patients with nonalcoholic fatty liver disease
par: Kawanaka M, et autres
Publié: (2015)

Clinical applications of the Model for End-Stage Liver Disease (MELD) in hepatic medicine
par: Lau T, et autres
Publié: (2013)

Risk stratification of patients with hepatocellular carcinoma undergoing trans arterial chemoembolization using an alpha-fetoprotein model
par: Mohamed Eltabbakh, et autres
Publié: (2021)

Type I interferon receptor in peripheral blood mononuclear cells may predict response to intra-arterial 5-fluorouracil + interferon therapy for advanced hepatocellular carcinoma
par: Korenaga K, et autres
Publié: (2011)

Serum anti-modified citrullinated vimentin antibody concentration is associated with liver fibrosis in patients with chronic hepatitis
par: Suad Abdeen, et autres
Publié: (2011)

Direct comparison of the FibroScan XL and M probes for assessment of liver fibrosis in obese and nonobese patients
par: Durango E, et autres
Publié: (2013)